Focal Medical, Inc. is a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative and patent protected targeted therapeutic system. The Company’s lead product is a targeted therapeutic product delivering gemcitabine (an FDA approved chemotherapeutic) actively and directly to the pancreas by non-circulatory pathways to treat pancreatic cancer.
Focal Medical, Inc. is formerly known as Advanced Chemotherapy Technologies, Inc.
It is headquartered in Cary, North Carolina.